产品名称 | 产品编号 | 浓度/详细参数 | CAS号 | 规格/计量单位 | 价格 | 货期 | 品牌 |
---|---|---|---|---|---|---|---|
Flumatinib mesylate | F648447-100mg | ≥99% | 895519-91-2 | 100mg | ¥ 13800.9 | 期货,请咨询 | 阿拉丁 |
FT206 | F648395-5mg | ≥98% | 2278274-34-1 | 5mg | ¥ 4000.9 | 期货,请咨询 | 阿拉丁 |
FT206 | F648395-50mg | ≥98% | 2278274-34-1 | 50mg | ¥ 22000.9 | 期货,请咨询 | 阿拉丁 |
FT206 | F648395-25mg | ≥98% | 2278274-34-1 | 25mg | ¥ 13500.9 | 期货,请咨询 | 阿拉丁 |
FT206 | F648395-10mg | ≥98% | 2278274-34-1 | 10mg | ¥ 6800.9 | 期货,请咨询 | 阿拉丁 |
FT206 | F648395-100mg | ≥98% | 2278274-34-1 | 100mg | ¥ 34000.9 | 期货,请咨询 | 阿拉丁 |
FAPI-4 | F648286-5mg | ≥98% | 2374782-02-0 | 5mg | ¥ 7800.9 | 期货,请咨询 | 阿拉丁 |
FAPI-4 | F648286-50mg | ≥98% | 2374782-02-0 | 50mg | ¥ 39500.9 | 期货,请咨询 | 阿拉丁 |
FAPI-4 | F648286-25mg | ≥98% | 2374782-02-0 | 25mg | ¥ 25500.9 | 期货,请咨询 | 阿拉丁 |
FAPI-4 | F648286-10mg | ≥98% | 2374782-02-0 | 10mg | ¥ 12500.9 | 期货,请咨询 | 阿拉丁 |
FGFR-IN-1 | F648239-5mg | ≥99% | 1513860-41-7 | 5mg | ¥ 10500.9 | 期货,请咨询 | 阿拉丁 |
FGFR-IN-1 | F648239-10mg | ≥99% | 1513860-41-7 | 10mg | ¥ 16500.9 | 期货,请咨询 | 阿拉丁 |
Fedovapagon | F648207-5mg | ≥99% | 347887-36-9 | 5mg | ¥ 1400.9 | 期货,请咨询 | 阿拉丁 |
Fedovapagon | F648207-50mg | ≥99% | 347887-36-9 | 50mg | ¥ 8500.9 | 期货,请咨询 | 阿拉丁 |
Fedovapagon | F648207-10mg | ≥99% | 347887-36-9 | 10mg | ¥ 2200.9 | 期货,请咨询 | 阿拉丁 |
Fingolimod-d4 | F648200-1mg | ≥98% | 1346747-38-3 | 1mg | ¥ 2400.9 | 期货,请咨询 | 阿拉丁 |
FKBP12 PROTAC dTAG-13 | F648183-5mg | ≥99% | 2064175-41-1 | 5mg | ¥ 5500.9 | 期货,请咨询 | 阿拉丁 |
FKBP12 PROTAC dTAG-13 | F648183-1mg | ≥99% | 2064175-41-1 | 1mg | ¥ 2095.9 | 期货,请咨询 | 阿拉丁 |
FKBP12 PROTAC dTAG-13 | F648183-10mg | ≥99% | 2064175-41-1 | 10mg | ¥ 8800.9 | 期货,请咨询 | 阿拉丁 |
FAAH-IN-1 | F648137-5mg | 1242441-47-9 | 5mg | ¥ 11400.9 | 期货,请咨询 | 阿拉丁 | |
FAAH-IN-1 | F648137-1mg | 1242441-47-9 | 1mg | ¥ 4500.9 | 期货,请咨询 | 阿拉丁 | |
FLT3-IN-10 | F648067-5mg | ≥98% | 2088735-51-5 | 5mg | ¥ 1600.9 | 期货,请咨询 | 阿拉丁 |
FLT3-IN-10 | F648067-50mg | ≥98% | 2088735-51-5 | 50mg | ¥ 8800.9 | 期货,请咨询 | 阿拉丁 |
FLT3-IN-10 | F648067-25mg | ≥98% | 2088735-51-5 | 25mg | ¥ 5500.9 | 期货,请咨询 | 阿拉丁 |